 |
 |
New Treatment Options for Parkinson's Disease Show Promise By staff - Posted on 01 July 2008 Phase 2 results with a new nonergot compound called pardoprunox appear promising, but adverse effects may be an issue. In a separate study, transdermal delivery of a levodopa prodrug increased levodopa levels in a small number of patients, raising hopes for a levodopa patch. Medscape Medical News Rayilyn Brown Director AZNPF Arizona Chapter National Parkinson Foundation [log in to unmask] ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn